Published on : Apr 20, 2018
Albany, New York, April 20, 2018: With a prime focus on anti-infective drugs, Market Research Hub (MRH) has publicized a study titled “Anti-infective Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025” to its massive repository, which offers a comprehensive analysis of the current market trends and future estimations in the market. Moreover, the report covers market dynamics including drivers, restraints opportunities, and trends expected to influence the global anti-infective drugs market growth during the said period. As per the research findings, the market for anti-infective drugs is in evolving stage. Analyst indicates that increase in the number of people suffering from viral infection across the globe is likely to drive the anti-infective drugs market from 2017 to 2025.
In the initial section, the reports present brief introduction about the anti-infective Drugs along with its market scope around the world and key industry developments. Additionally, market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different regions.
As per the active research evaluations, the global market was valued at US$ 106.5 Bn in 2016 and is projected to expand at a CAGR of 4.2% from 2017 to 2025. Also, by 2025 end, the market value is estimated to reach US$ 153.3 Bn. The report also adds that increase in digitization of dental practices, high healthcare IT budgets, and rise in demand for chair time optimization in developed markets are the prime factors behind the estimated growth.
For a clear understanding, the anti-infective drugs market has been segmented on the basis of type, indication, distribution channel and geography. Geographically, the market spread has been analyzed in major regions including North America, Middle East & Africa (MEA), Japan, Europe, the Asia Pacific excluding Japan, and Latin America; the regions are analyzed in terms of revenue and volume generation along with the CAGR for the period from 2017 to 2025.
Based on the type, the global anti-infective drugs market has been segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In terms of indication, the market has been classified into HIV infection, pneumonia, methicillin-resistant Staphylococcus aureus (MRSA), sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, respiratory virus infection. Based on distribution channel, the study covers hospital pharmacy, retail pharmacy, and online sales.
As per the estimations, the HIV infection segment dominated the global market and the trend is likely to continue by the end of 2025 with the marginal increase in market share. On the basis of geography, North America and Europe are projected to dominate the global anti-infective drugs market. On the other hand, Asia Pacific is anticipated to be the fastest growing market in the coming years.
Another vital section of the report is competitive landscape featuring some of the top companies, including Merck & Co., Inc., F. Hoffman-La Roche Ltd., Bayer AG, Pfizer, Inc., Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Sanofi, Allergen plc, and Johnson and Johnson.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1714440
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org